» Related Searches: breast, breast cancer, breast cancer research, big breast lovers, types breast cancer

AstraZeneca [Pressemappe] Macclesfield, England, November 17 (ots/PRNewswire) - FOR
INTERNATIONAL JOURNALISTS - NOT FOR US MEDIA - Data Published in the Lancet Oncology
Report That Patients are More Likely to … 
GlaxoSmithKline said its new breast-cancer pill, Tykerb, will receive a priority
review from the FDA … 
… breast cancer is no match for the multibillion-dollar corporations that run the
energy capital of America. But that's only one of the assumptions being tested in a strike
of 1,700 … 
… breast cancer at the age of 39 in August. The Northern Ireland golfer informed
tournament organizers that he is not up to making the trip to Australia. "He's just
emotionally … 
Women with early-stage, hormone-sensitive breast cancer are significantly more likely
to beat the disease if they switch to a new drug, according to research to be published
today … 
WOMEN who switch to Arimidex, a new post-op breast cancer drug approved for use in
Scotland this week, increase their chances of survival by 29 per cent, according to a … 
LONDON (Reuters) - Switching patients with early breast cancer from a standard drug
to a newer treatment helps them to live longer and improves their odds of remaining free
of … 
The new indication is for Herceptin, in combination with other cancer drugs, for the
treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy) … 
… breast cancer drug Herceptin to include women with early-stage cancer who have
undergone surgery, the company said on Thursday. (Luke MacGregor/Reuters) … 